EP Patent

EP1568369A1 — Use of meloxicam for the treatment of respiratory diseases in pigs

Assigned to Boehringer Ingelheim Vetmedica GmbH · Expires 2005-08-31 · 21y expired

What this patent protects

The invention relates to the use of meloxicam or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment or prevention of respiratory diseases in pigs.

USPTO Abstract

The invention relates to the use of meloxicam or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment or prevention of respiratory diseases in pigs.

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: EP1568369A1
Jurisdiction: EP
Classification: —
Expires: 2005-08-31
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Vetmedica GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.